The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors

Overview of attention for article published in BMC Cancer, August 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 5,128 followers.

The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors #lymphoma #lymsm https://t.co/Pcb4AEieUy

01 Sep 2021

Reply Repost Favourite

RT @DCell_papers: The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors https://…

01 Sep 2021

Reply Repost Favourite

The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors https://t.co/96b7ll7UQL

31 Aug 2021

Reply Repost Favourite

The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors #lymphoma #lymsm https://t.co/Sr8i6C2LT8

31 Aug 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.